These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
534 related items for PubMed ID: 17721992
1. Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national survey. Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D, Johannesen TB, Mella O, Espeland A. Cancer; 2007 Oct 15; 110(8):1803-14. PubMed ID: 17721992 [Abstract] [Full Text] [Related]
2. Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway. Salvesen Haldorsen I, Aarseth JH, Hollender A, Larsen JL, Espeland A, Mella O. Acta Oncol; 2004 Oct 15; 43(6):520-9. PubMed ID: 15370608 [Abstract] [Full Text] [Related]
3. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis. Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE. Cancer; 2005 Dec 01; 104(11):2466-72. PubMed ID: 16240449 [Abstract] [Full Text] [Related]
4. Patterns of treatment in older adults with primary central nervous system lymphoma. Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE. Cancer; 2007 Sep 15; 110(6):1338-44. PubMed ID: 17647247 [Abstract] [Full Text] [Related]
5. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ, Lin TY, He YJ, Huang HQ, Xia ZJ, Xia YF, Xu RH, Guo Y, Guan ZZ. Ai Zheng; 2006 Apr 15; 25(4):476-80. PubMed ID: 16613684 [Abstract] [Full Text] [Related]
6. Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Newell ME, Hoy JF, Cooper SG, DeGraaff B, Grulich AE, Bryant M, Millar JL, Brew BJ, Quinn DI. Cancer; 2004 Jun 15; 100(12):2627-36. PubMed ID: 15197806 [Abstract] [Full Text] [Related]
7. Results of radiation monotherapy for primary central nervous system lymphoma in the 1990s. Shibamoto Y, Ogino H, Hasegawa M, Suzuki K, Nishio M, Fujii T, Kato E, Ishihara S, Sougawa M, Kenjo M, Kawamura T, Hayabuchi N. Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):809-13. PubMed ID: 15936564 [Abstract] [Full Text] [Related]
8. Delayed neurotoxicity in primary central nervous system lymphoma. Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE. Arch Neurol; 2005 Oct 01; 62(10):1595-600. PubMed ID: 16216945 [Abstract] [Full Text] [Related]
9. Primary central nervous system lymphoma. Results at the University of California at Los Angeles and review of the literature. Selch MT, Shimizu KT, De Salles AF, Sutton C, Parker RG. Am J Clin Oncol; 1994 Aug 01; 17(4):286-93. PubMed ID: 8048389 [Abstract] [Full Text] [Related]
10. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency. Shenkier TN, Voss N, Chhanabhai M, Fairey R, Gascoyne RD, Hoskins P, Klasa R, Morris J, O'Reilly SE, Pickles T, Sehn L, Connors JM. Cancer; 2005 Mar 01; 103(5):1008-17. PubMed ID: 15651059 [Abstract] [Full Text] [Related]
11. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Olson JE, Janney CA, Rao RD, Cerhan JR, Kurtin PJ, Schiff D, Kaplan RS, O'Neill BP. Cancer; 2002 Oct 01; 95(7):1504-10. PubMed ID: 12237919 [Abstract] [Full Text] [Related]
12. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Makino K, Nakamura H, Kino T, Takeshima H, Kuratsu J. Surg Neurol; 2006 Nov 01; 66(5):503-6. PubMed ID: 17084198 [Abstract] [Full Text] [Related]
13. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL). Raez LE, Patel P, Feun L, Restrepo A, Raub WA, Cassileth PA. Crit Rev Oncog; 1998 Nov 01; 9(3-4):199-208. PubMed ID: 10201628 [Abstract] [Full Text] [Related]
14. Characteristics and outcomes of elderly patients with primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center experience. Ney DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE. Cancer; 2010 Oct 01; 116(19):4605-12. PubMed ID: 20572045 [Abstract] [Full Text] [Related]
15. Primary central nervous system lymphoma. Ferreri AJ, Reni M. Crit Rev Oncol Hematol; 2007 Sep 01; 63(3):257-68. PubMed ID: 17590348 [Abstract] [Full Text] [Related]
16. Primary central nervous system lymphoma: a profile of 26 cases from Western India. Agarwal PA, Menon S, Smruti BK, Singhal BS. Neurol India; 2009 Sep 01; 57(6):756-63. PubMed ID: 20139505 [Abstract] [Full Text] [Related]
17. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. van der Sanden GA, Schouten LJ, van Dijck JA, van Andel JP, van der Maazen RW, Coebergh JW, Working Group of Specialists in Neuro-Oncology in the Southern and Eastern Netherlands. Cancer; 2002 Mar 01; 94(5):1548-56. PubMed ID: 11920513 [Abstract] [Full Text] [Related]
18. [Primary central nervous system lymphoma: a report of 28 patients]. Hu Y, Feng FY, Shi YK, Zhou LQ, Gu DZ, Wang QL. Zhonghua Zhong Liu Za Zhi; 2004 Jun 01; 26(6):375-8. PubMed ID: 15312352 [Abstract] [Full Text] [Related]
19. Primary central nervous system lymphoma: monocenter, long-term, intent-to-treat analysis. Kiewe P, Fischer L, Martus P, Thiel E, Korfel A. Cancer; 2008 Apr 15; 112(8):1812-20. PubMed ID: 18318432 [Abstract] [Full Text] [Related]
20. [Treatment of primary central nervous system lymphoma in the immunocompetent patient]. Sierra Del Rio M, Benouaich-Amiel A, Psimaras D, Dehais C, Hoang-Xuan K. Rev Neurol (Paris); 2008 Apr 15; 164(6-7):569-74. PubMed ID: 18565356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]